Skip to search.
 All Ordinaries Up 0.39%

More On SNTA

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqCM
0.34 0.00(0.00%) 23 Jul 06:00
Prev Close:0.34
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:0.652511
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.15 - 2.23
Volume:0
Avg Vol (3m):781,843
Market Cap:47.14M
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTA 0.00%47.14M
INFIUp 0.62%80.10M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback